Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamune vs Standard of Care in De Novo Renal Transplant Recipients
NCT01601821Phase 4Completed
- Sponsor
- Pfizer
- Start
- Apr 2006
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sirolimus in kidney transplantation (2 arms), sponsored by Pfizer. Primary endpoint: Incidence of Efficacy Failure at 12 months. Started Apr 2006; status: completed.
02
Drugs
sirolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT01601821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01601821.